Total Funding
91
73
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
7321
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
- Melinda Thomas: COO and Co-Founder
- Maital Rasmussen: Chief Commercial Officer (CCO)Past Role: Roche, Global Head of Marketing, Roche (DIS)
About the Company
Octave develops and offers a blood-based diagnostic platform focused on measuring disease activity in neurodegenerative conditions. It provides the Octave MSDA Test, a multi-analyte biomarker assay that quantifies levels of multiple proteins to assess activity in multiple sclerosis. The company supports clinicians and patients by transforming
biomarker data into individualized reports that inform treatment decisions. It continues to expand research into additional biomarkers and disease progression models in neurodegeneration.
Women Founded
